Sermorelin
Also known as: GRF 1-29 · Geref
A bioidentical analog of growth hormone-releasing hormone (GHRH). The bedrock of clinical anti-aging endocrinology, prescribed to safely restore youthful IGF-1 levels and improve sleep.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~10–20 minutes
200–300 mcg before bed
Subcutaneous injection
Mechanism of Action
Binds GHRH receptors on pituitary somatotrophs to trigger physiological, pulsatile growth hormone release that mirrors natural circadian patterns.
Key Research Areas
Frequently Asked Questions
What is Sermorelin?▾
How does Sermorelin work?▾
What is the recommended dosage for Sermorelin?▾
What is the half-life of Sermorelin?▾
Is Sermorelin FDA approved?▾
Research Disclaimer
The information provided about Sermorelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.